Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Related Posts
On the Record: Startup aims to turn scientific researchers into ‘deep-tech’ entrepreneurs
Justin Hafner, founder and former CEO of digital health startup Kinotek, aims to make an even bigger splash in the startup world...
Skincare startup funds UMaine scholarship to spark innovation
Marin Skincare, known for its Lobster Lotion product, partnered with the University of Maine to create a scholarship to spur innovation and...
Bigelow Lab looks to create ‘blue’ biotechnology businesses and jobs
Bigelow Laboratory for Ocean Sciences, an East Boothbay nonprofit research institute focused on global ocean health, last week launched a program...